Delivery Order SPE2DB25D3012-SPE2DB25FWYBT
- Not listed
- The Defense Logistics Agency awarded a $2,239.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.29 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The award, issued on August 15, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,677.69 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,920.81 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is set for completion by July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.76 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and narcolepsy. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $3,007.07 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $3,178.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. The pharmaceutical supply will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,254.20 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract, which was competitively awarded without a set-aside designation, carries a firm fixed price structure and an ultimate completion date of September 3, 2025. AmerisourceBergen will perform this work at its corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $3,848.78 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded on September 12, 2025, with an ultimate completion date of September 15, 2025, and represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.42 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYBTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,052.14 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this order. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. This prime contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order represents a routine pharmaceutical procurement fulfilling ongoing medical supply needs within this established contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 6/18/25 |